Skip to main content
. 2017 Sep 29;7:12432. doi: 10.1038/s41598-017-12810-9

Figure 2.

Figure 2

Survival, weight and food and water consumption. (A) Survival curve of VMAT2lox/lox mice bilaterally injected with AAV2-GFP (n = 7) or AAV2-CRE-GFP (n = 8) in the SN (Log-rank (Mantel-Cox) test: p < 0.001). (B) Weight curve of VMAT2lox/lox mice bilaterally injected with AAV2-GFP (n = 13) or AAV2-CRE-GFP (n = 11) in the SN (Mann-Whitney U: AAV2-GFP vs AAV2-CRE-GFP: Week 0: p = 0.91; Week 4: p = 0.91; Week 8: p = 0.88; Week 12: p = 0.43; Week 16: **p < 0.01). (C) Food and water consumption of VMAT2lox/lox mice bilaterally injected with AAV2-GFP (n = 7) or AAV2-CRE-GFP (n = 7) in the SN at 8 and 16 weeks’ post-virus injection (Mann-Whitney U: AAV2-GFP vs AAV2-CRE-GFP: Food consumption: Week 8: p = 0.14; Week 16: *p < 0.05; Water consumption: Week 8: p = 0.53; Week 16: **p < 0.01). SN: Substancia nigra, VMAT2: Vesicular Monoamine Transporter-2, AAV: Adenoassociated Virus.